Curry S J, Taplin S H, Anderman C, Barlow W E, McBride C
Center for Health Studies, Group Health Cooperative of Puget Sound, Seattle, Washington 98101.
Prev Med. 1993 May;22(3):350-60. doi: 10.1006/pmed.1993.1029.
Although rates of mammography screening among women in the general population have been increasing they still fall short of national goals. This study evaluated the effects on rates of participation in mammography screening of obtaining risk factor information and providing general or personalized risk information through direct mailed correspondence.
Women enrollees in a health maintenance organization (N = 2,076), age 50 and above, were randomized to one of the following four groups: (a) no risk factor questionnaire + generic invitation, (b) no risk factor questionnaire + general risk invitation, (c) risk factor questionnaire + general risk invitation, and (d) risk factor questionnaire + personal risk invitation. Computerized visit records were monitored for 12 months following a mailed invitation to assess whether a mammogram had been obtained.
Overall participation was 37.5% and the rate of participation did not differ significantly across groups (P = 0.26). Participation was related to age (P < 0.02), with rates highest for women ages 60-69 years (42.7%) compared with those for women ages 50-59 (35.5%) and those age 70+ (33.7%). Among women with a family history of breast cancer, the personalized risk invitation was associated with significantly higher participation compared with general risk invitation (66.7 versus 42.9%, respectively; P < 0.003).
Women with a family history of breast cancer are more likely to obtain a mammogram if that fact is reinforced as a risk factor. Research on environmental barriers to mammography screening may suggest alternative strategies for increasing participation.
尽管普通人群中女性的乳腺钼靶筛查率一直在上升,但仍未达到国家目标。本研究评估了通过直接邮寄信件获取风险因素信息并提供一般或个性化风险信息对乳腺钼靶筛查参与率的影响。
将年龄在50岁及以上的健康维护组织的女性参保者(N = 2076)随机分为以下四组之一:(a)无风险因素问卷+普通邀请,(b)无风险因素问卷+一般风险邀请,(c)风险因素问卷+一般风险邀请,以及(d)风险因素问卷+个人风险邀请。在邮寄邀请后的12个月内监测计算机化的就诊记录,以评估是否进行了乳腺钼靶检查。
总体参与率为37.5%,各组之间的参与率无显著差异(P = 0.26)。参与率与年龄有关(P < 0.02),60 - 69岁女性的参与率最高(42.7%),而50 - 59岁女性的参与率为35.5%,70岁及以上女性的参与率为33.7%。在有乳腺癌家族史的女性中,与一般风险邀请相比,个性化风险邀请与显著更高的参与率相关(分别为66.7%和42.9%;P < 0.003)。
如果将有乳腺癌家族史这一事实作为风险因素加以强化,有乳腺癌家族史的女性更有可能进行乳腺钼靶检查。对乳腺钼靶筛查的环境障碍进行研究可能会提出提高参与率的替代策略。